Sillajen Biotherapeuticsincis Located In San Franciscoone Of The Largest And Most Innovative Biotech Clusters In The Worldsillajen Biotherapeutics Focuses On The Researchdevelopment And Manufacturing Of Oncolytic Viruses To Treat Cancerwe Are Responsible For Clinical Operationsregulatory Affairsresearch And Developmentmanufacturingalliance Management And Accounting For Clinical Trials Sillajenincis A South Korean Based Biotechnology Company Headquartered In Busan South Koreawith Satellite Offices In Seoulsouth Korea And San Franciscoca The Company Is Focused On The Development And Commercialization Of Oncolytic Immunotherapy Products Using The Solvetm Platformincluding Its Lead Product Pexa Vecwhich Is Currently In Phase 3 Trials For The Treatment Of Advanced Primary Liver Canceradditional Information About Sillajen Is Available At Www Sillajen Com
United States
